The use of molecular volumetric parameters for the evaluation of Lu-177 PSMA I&T therapy response and survival

被引：0
|
作者：
Emine Acar
Özhan Özdoğan
Ayşegül Aksu
Erkan Derebek
Recep Bekiş
Gamze Çapa Kaya
机构：
[1] İzmir Kâtip Çelebi University,Department of Nuclear Medicine, Ataturk Training and Research Hospital
[2] Dokuz Eylul University,Department of Translational Oncology, Institute of Health Sciences
[3] Dokuz Eylul University,Department of Nuclear Medicine, School of Medicine
来源：
Annals of Nuclear Medicine | 2019年 / 33卷
关键词：
PSMA; MTV; TLG; Tumor volume; Precision medicine; Theranostic;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：681 / 688
页数：7
相关论文
共 50 条
  • [1] The use of molecular volumetric parameters for the evaluation of Lu-177 PSMA I&T therapy response and survival
    Acar, Emine
    Ozdogan, Ozhan
    Aksu, Aysegul
    Derebek, Erkan
    Bekis, Recep
    Kaya, Gamze Capa
    ANNALS OF NUCLEAR MEDICINE, 2019, 33 (09) : 681 - 688
  • [2] Lu-177 PSMA I&T Therapy for Prostate Cancer; Treatment Response, Treatment Toxicity, and Survival Results
    Acar, Emine
    Sonmezer, Burak
    Derebek, Erkan
    Bekis, Recep
    Ozdogan, Ozhan
    Kaya, Gamze Capa
    JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES, 2019, 3 (03): : 158 - 164
  • [3] PSMA Radioligand Therapy of Metastasized Prostate Cancer Using Lu-177 PSMA I&T and Lu-177 PSMA-617: First comparative Dosimetric Results
    Schuchardt, C.
    Kulkarni, H. R.
    Wiessalla, S.
    Shahinfar, M.
    Singh, A.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S36 - S37
  • [4] PSMA Radioligand Therapy (PRLT) using Lu-177 PSMA I&T and Lu-177 PSMA-617: Intra-individual comparison of kinetics and dosimetry
    Schuchardt, C.
    Kulkarni, H. R.
    Wiessalla, S.
    Shahinfar, M.
    Singh, A.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S214 - S214
  • [5] Preliminary Results of Lu-177 PSMA I&T Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer
    Hekimsoy, T.
    Gorur, G. Daglioz
    Isgoren, S.
    Demir, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S592 - S593
  • [6] Radioligand Therapy with [177Lu]Lu-PSMA I&T in the Elderly - Safety, Efficacy and Prognosticators of Survival
    Weber, S.
    Seitz, A.
    Kuebler, H.
    Buck, A. K.
    Werner, R. A.
    Hartrampf, P. E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S151 - S151
  • [7] Therapy of Metastasized Prostate Cancer Using a Lu-177 Labeled PSMA Inhibitor (I&T): First Dosimetric Results in Patients
    Schuchardt, C.
    Wiessalla, S.
    Ozkan, A.
    Kulkarni, H. R.
    Shahinfar, M.
    Sayeg, M.
    Weineisen, M.
    Wester, H. J.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S99 - S99
  • [8] Improved quality control of [177Lu]Lu-PSMA I&T
    Kraihammer, Martin
    Garnuszek, Piotr
    Bauman, Andreas
    Maurin, Michael
    Lafont, Manuel Alejandre
    Haubner, Roland
    von Guggenberg, Elisabeth
    Gabriel, Michael
    Decristoforo, Clemens
    EJNMMI RADIOPHARMACY AND CHEMISTRY, 2023, 8 (01)
  • [9] Improved quality control of [177Lu]Lu-PSMA I&T
    Martin Kraihammer
    Piotr Garnuszek
    Andreas Bauman
    Michael Maurin
    Manuel Alejandre Lafont
    Roland Haubner
    Elisabeth von Guggenberg
    Michael Gabriel
    Clemens Decristoforo
    EJNMMI Radiopharmacy and Chemistry, 8
  • [10] Optimising the Synthesis and QC of [177Lu]Lu-PSMA I&T for Prostate Cancer Therapy
    Hong, K.
    Fincher, L.
    Browne, E.
    INTERNAL MEDICINE JOURNAL, 2022, 52 : 53 - 54
12345